Aurobindo Pharma reported INR88.53B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Cipla INR 65.41B 9.77B Mar/2026
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Hindustan Unilever INR 159.96B 2.01B Mar/2026
Sun Pharmaceuticals INR 145.86B 2.13B Mar/2026
UPL INR 183.35B 59.74B Mar/2026